CRISPR Therapeutics
CRSP
#3489
Rank
C$3.98 B
Marketcap
$46.40
Share price
-0.03%
Change (1 day)
-46.88%
Change (1 year)

Earnings for CRISPR Therapeutics (CRSP)

Earnings in 2024 (TTM): -C$0.5 Billion

According to CRISPR Therapeutics's latest financial reports the company's current earnings are C$35 Million. a decrease over its 2023 earnings that were of -C$0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CRISPR Therapeutics from 2016 to 2024

Annual earnings

Year Earnings Change
2024 -C$0.52 Billion140.62%
2023 -C$0.22 Billion-76.83%
2022 -C$0.93 Billion-271.4%
2021 C$0.53 B-209.04%
2020 -C$0.5 Billion-617.12%
2019 C$95.66 M-140.93%
2018 -C$0.24 Billion146.86%
2017 -C$94.67 Million193.19%
2016 -C$32.29 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.21 Billion-60.60%๐Ÿ‡บ๐Ÿ‡ธ USA